Precision Oncology
Overview of innovation
The toTIL Score is an innovative scoring system designed to predict the likelihood of cancer patients responding to immunotherapy based on the level of tumour-infiltrating lymphocytes (TILs) within the tumour. By evaluating the extent and distribution of TIL infiltration, the toTIL Score provides a quantifiable metric that helps clinicians determine the potential effectiveness of immunotherapy for individual patients. This system aims to enhance personalised treatment plans, improve response rates, and reduce unnecessary exposure to costly and potentially toxic treatments.
Type of Intellectual Property protection
Know how
Copyright
Innovation Opportunity Type
Funding
Partnership
Industry
Information and communication
Information service activities
Professional, scientific and technical activities
Scientific research and development
Human health and social work activities
Human health activities
Technology Readiness Level
TRL 5 – Prototype tested in a controlled environment
Website link
https://app.in-part.com/university-dashboard/technologies/20076